FDA Drug recall D-0331-2021
Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14
- FDA Drug
- Class III
- terminated
- Published 2021-04-21
On 2021-04-21 the FDA classified a Class III recall of Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14 by Teligent Pharma, citing failed Stability Specifications: product did not meet viscosity results.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0331-2021 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2021-03-29 |
| Published | 2021-04-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teligent Pharma |
| Distribution | US |
Product
Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.
Reason
Failed Stability Specifications: product did not meet viscosity results.
Identifiers
| code_info | Lot 13269, Exp March 2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0331-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.